The influence of rituximab, high-dose therapy followed by autologous stem cell transplantation, and age in patients with primary CNS lymphoma
Crossref DOI link: https://doi.org/10.1007/s00277-015-2470-4
Published Online: 2015-08-14
Published Print: 2015-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Madle, M.
Krämer, I.
Lehners, N.
Schwarzbich, M.
Wuchter, P.
Herfarth, K.
Egerer, G.
Ho, A.D.
Witzens-Harig, M.
Text and Data Mining valid from 2015-08-14